du-21220 has been researched along with Kidney Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, N; Hayashi, K; Ohtsu, F; Sakakibara, J; Yano, R | 1 |
| Hiraoka, M; Hosokawa, K; Kobata, R; Kotsuji, F; Mayumi, M; Ohta, N; Shukunami, K; Tsukahara, H; Yamashita, N | 1 |
2 other study(ies) available for du-21220 and Kidney Diseases
| Article | Year |
|---|---|
[Risk factors and subjective symptoms of drug-induced leucopenia].
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Aged, 80 and over; Autoimmune Diseases; Case-Control Studies; Child; Databases, Factual; Female; Humans; Kidney Diseases; Leukopenia; Logistic Models; Male; Methimazole; Methotrexate; Middle Aged; Risk Factors; Ritodrine; Sex Factors; Ticlopidine; Young Adult | 2011 |
Infantile renal dysfunction associated with intrauterine exposure to ritodrine and magnesium sulfate.
Topics: Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kidney Diseases; Magnesium Sulfate; Male; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Ritodrine; Tocolytic Agents | 2002 |